Green Synthesized Al₂O₃ Nanocatalyst for Efficient Synthesis of Nicotinonitrile Derivatives: Catalytic Performance, Antimicrobial Activity and In-Silico Evaluation

In the world of medicine and materials science, the way we build molecules matters as much as the molecules themselves. For decades, creating complex chemical structures has often required harsh conditions: high heat, toxic solvents, and catalysts that cannot be reused, leaving behind a trail of chemical waste. Scientists are increasingly turning toward "green" chemistry, a philosophy that seeks to perform these same chemical transformations using nature-friendly methods, safer materials, and less energy. At the heart of this shift are nanoparticles, tiny particles of matter so small that they possess unique properties, such as a massive surface area relative to their size, which makes them incredibly efficient at speeding up reactions. Among these, aluminum oxide, a common and stable material, has shown great promise as a catalyst, but finding a way to make it without generating pollution has been a challenge.

A team of researchers in India has now demonstrated a way to create these aluminum oxide nanoparticles using a simple leaf extract, and then use them to build a specific class of drug-like molecules called nicotinonitrile derivatives. These derivatives are important because they serve as the structural backbone for many compounds with potential to fight bacterial infections. The researchers, led by Prakash Kokare and Santosh Kamble, developed a process that avoids the high temperatures and toxic chemicals typical of traditional methods. Instead, they used an extract from the leaves of the Coccinia indica plant, a common vine found in India, to guide the formation of the nanoparticles. This plant extract acts as a natural helper, or "capping agent," that prevents the tiny particles from clumping together and ensures they form correctly, all while keeping the process non-toxic and environmentally sound.

Once the nanoparticles were created, the team put them to work in a laboratory setting to synthesize the nicotinonitrile molecules. They mixed the nanoparticles with a combination of aromatic aldehydes, acetophenone, and ammonium acetate in a solvent made of equal parts ethanol and water. The reaction took place at a gentle temperature of 65 degrees Celsius, a significant drop from the hundreds of degrees often required by other methods. The results were striking: the reaction completed in as little as 18 minutes, producing the desired molecules with yields as high as 96 percent. The catalyst proved to be robust; after the reaction, the solid nanoparticles could be easily filtered out, washed, and used again. The team ran the process five times in a row, and the catalyst maintained its high efficiency with only a very slight drop in performance, proving it could be a sustainable tool for repeated use.

The study did not stop at making the molecules; the researchers also investigated whether these new compounds could actually fight bacteria. They tested the synthesized derivatives against four common bacterial strains, including Staphylococcus aureus and Escherichia coli. The results showed that the new compounds were effective at inhibiting the growth of these bacteria. To understand how they might work, the team used computer simulations to see how the molecules interacted with a specific bacterial enzyme called DNA gyrase B, which is essential for the bacteria to copy its genetic material. The simulations suggested that the new compounds could bind tightly to this enzyme, potentially blocking it and stopping the bacteria from reproducing. One compound, in particular, showed a very strong interaction with the enzyme in the computer model, even outperforming a standard reference drug in the simulation.

Beyond their potential to fight infection, the researchers also checked the safety profile of these new molecules using computer models. They looked at how the body might process the compounds and whether they would cause harm to organs like the liver or kidneys. The analysis suggested that most of the compounds have favorable properties for being used as drugs, meaning they are likely to be absorbed well and do not appear to be highly toxic. The study concludes that this approach offers a dual benefit: it provides a clean, efficient way to manufacture important chemical building blocks using a reusable catalyst, and it produces molecules that show promise as future antibacterial agents. By combining a green synthesis method with the creation of biologically active compounds, the work highlights a path forward for sustainable chemistry that is both practical and protective of the environment.